AbstractBackgroundProphylactic paracetamol (PP) was previously shown to reduce primary and booster antibody responses against the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). This study further evaluated the effect of PP on antibody persistence, immunological memory and nasopharyngeal carriage (NPC).MethodsTwo hundred and twenty children previously primed (3 doses, NCT00370318) and boosted (NCT00496015) with PHiD-CV with (PP group) or without (NPP group) prophylactic paracetamol administration received one PHiD-CV dose in their fourth year of life to assess the induction of immunological memory following previous immunisations. A control group of age-matched unprimed children enrolled in ...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
AbstractBackgroundProphylactic paracetamol (PP) was previously shown to reduce primary and booster a...
Memory B cells are long-lived and could contribute to persistence of humoral immunity by maintaining...
BACKGROUND: Vaccine-induced immunity against pneumococcal infection relies on the generation of high...
AbstractBackgroundTo provide broader protection against pneumococcal disease, new vaccines containin...
Pneumococcal polysaccharide vaccine (PPV) is of limited immunogenicity in infants and immunocompro-m...
Background The impact on carriage and optimal schedule for primary vaccination of older children ...
BACKGROUND: A 9-valent pneumococcal conjugate vaccine (PCV-9), given in a 3-dose schedule, protected...
Pneumococcal conjugate vaccines (PCVs) have been successful in preventing invasive pneumococcal dise...
AbstractBrazil introduced the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D c...
Background: Although both the 13-valent pneumococcal conjugate vaccine (PCV13) and the 10-valent pn...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
AbstractBackgroundProphylactic paracetamol (PP) was previously shown to reduce primary and booster a...
Memory B cells are long-lived and could contribute to persistence of humoral immunity by maintaining...
BACKGROUND: Vaccine-induced immunity against pneumococcal infection relies on the generation of high...
AbstractBackgroundTo provide broader protection against pneumococcal disease, new vaccines containin...
Pneumococcal polysaccharide vaccine (PPV) is of limited immunogenicity in infants and immunocompro-m...
Background The impact on carriage and optimal schedule for primary vaccination of older children ...
BACKGROUND: A 9-valent pneumococcal conjugate vaccine (PCV-9), given in a 3-dose schedule, protected...
Pneumococcal conjugate vaccines (PCVs) have been successful in preventing invasive pneumococcal dise...
AbstractBrazil introduced the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D c...
Background: Although both the 13-valent pneumococcal conjugate vaccine (PCV13) and the 10-valent pn...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...
Pneumococcal protein-polysaccharide conjugate vaccines provide direct protection against Streptococc...